Metabolite Structure Analysis by High-Resolution MS: Supporting Drug-Development Studies

• Hughes JP , ReesS, KalindjianSB, PhilpottKL. Principles of early drug discovery. Br. J. Pharmacol. 162(6), 1239–1249 (2011).
   PubMed Web of Science ®Google Scholar
• Jorgensen WL . Efficient drug lead discovery and optimization. Acc. Chem. Res. 42(6), 724–733 (2009).
   PubMed Web of Science ®Google Scholar
• Kerns EH , DiL. Pharmaceutical profiling in drug discovery. Drug Discov. Today8(7), 316–323 (2003).
   PubMed Web of Science ®Google Scholar
• McKim JM Jr . Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Comb. Chem. High Throughput. Screen. 13(2), 188–206 (2010).
   PubMed Web of Science ®Google Scholar
• Anderson S , Luffer-AtlasD, KnadlerMP. Predicting circulating human metabolites: how good are we? Chem. Res. Toxicol. 22(2), 243–256 (2009).
   PubMed Web of Science ®Google Scholar
• Dalvie D , ObachRS, KangPet al. Assessment of three human in vitro systems in generation of major human excretory and circulating metabolites. Chem. Res. Toxicol. 22(2), 357–368 (2009).
   PubMed Web of Science ®Google Scholar
• Penner N , ClunkL, PrakashC. Human radiolabeled mass balance studies: objectives, utilities and applications. Biopharm. Drug Disp. 30(4), 185–203 (2009).
   PubMed Web of Science ®Google Scholar
• Roffey S , ObachR, GedgeJ, SmithD. What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metab. Rev. 39(1), 17–43 (2007).
   PubMed Web of Science ®Google Scholar
• Dear G , BeaumontC, RobertsAet al. Approaches for the rapid identification of drug metabolites in early clinical studies. Bioanalysis3(2), 197–213 (2011).
   PubMed Web of Science ®Google Scholar
• Gao H , DengS, ObachR. A simple liquid chromatography–tandem MS method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments. Drug Metab. Disp. 38(12), 2147–2156 (2010).
   PubMed Web of Science ®Google Scholar
• Obach RS , NeddermannA, SmithDA. Radiolabelled mass-balance excretion and metabolism studies in labatory animals: are they still necessary? Xenobiotica42(1), 46–56 (2012).
   PubMed Web of Science ®Google Scholar
• Ma S , Zhu M. Recent advances in applications of liquid-chromatography MS to the analysis of reactive drug metabolites. Chemico-Biological Interactions179(1), 25–37 (2009).
   PubMed Web of Science ®Google Scholar
• Annesley TM . Ion suppression in MS. Clin. Chem. 49(7), 1041–1044 (2003).
   PubMed Web of Science ®Google Scholar
• Nakamura M . Analyses of benzodiazepines and their metabolites in various biological matrices by LC–MS(/MS). Biomed. Chromatogr. 25(12), 1283–1307 (2011).
   PubMed Web of Science ®Google Scholar
• Dams R , HuestisMA, LambertWE, MurphyCM. Matrix effect in bio-analysis of illicit drugs with LC–MS/MS: influence of ionization type, sample preparation, and biofluid. J. Am. Soc. Mass Spectrom. 14(11), 1290–1294 (2003).
   PubMed Web of Science ®Google Scholar
• Meyer M , HH M. Current applications of high-resolution MS in drug metabolism studies. Anal. Bioanal. Chem. 403(5), 1221–1231 (2012).
   PubMed Web of Science ®Google Scholar
• Ma S , ChowdhurySK, AltonKB. Application of MS for metabolite identification. Curr. Drug Metab7(5), 503–523 (2006).
   PubMed Web of Science ®Google Scholar
• Korfmacher WA . Principles and applications of LC–MS in new drug discovery. Drug Discov. Today10(20), 1357–1367 (2005).
   PubMed Web of Science ®Google Scholar
• Want EJ , CravattBF, SiuzdakG. The expanding role of MS in metabolite profiling and characterization. Chembiochem. 6(11), 1941–1951 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang NR , YuS, TillerP, YehS, MahanE, EmaryWB. Quantitation of small molecules using high-resolution accurate mass spectrometers – a different approach for analysis of biological samples. Rapid Commun. Mass Spectrom. 23(7), 1085–1094 (2009).
   PubMed Web of Science ®Google Scholar
• Bateman KP , KellmannM, MuensterH, PappR, TaylorL. Quantitative–qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20(8), 1441–1450 (2009).
   PubMed Web of Science ®Google Scholar
• Mann M , Kelleher NL. Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl Acad. Sci. USA105(47), 18132–18138 (2008).
   PubMed Web of Science ®Google Scholar
• Barbara JE , KazmiF, MuranjanS, TorenPC, ParkinsonA. High-resolution MS elucidates metabonate (false metabolite) formation from alkylamine drugs during in vitro metabolite profiling. Drug Metab. Dispos. 40(10), 1966–1975 (2012).
   PubMed Web of Science ®Google Scholar
• Wei X , SunW, ShiXet al. MetSign: a computational platform for high-resolution MS-based metabolomics. Anal. Chem. 83(20), 7668–7675 (2011).
   PubMed Web of Science ®Google Scholar
• Ma S , Chowdhury SK. Application of LC-high-resolution MS with ‘intelligent’ data mining tools for screening reactive drug metabolites. Bioanalysis4(5), 501–510 (2012).
   PubMed Web of Science ®Google Scholar
• Castellino S , GrosecloseMR, WagnerD. MALDI imaging MS: bridging biology and chemistry in drug development. Bioanalysis3(21), 2427–2441 (2011).
   PubMed Web of Science ®Google Scholar
• Rompp A , GuentherS, TakatsZ, SpenglerB. Mass spectrometry imaging with high resolution in mass and space (HR(2) MSI) for reliable investigation of drug compound distributions on the cellular level. Anal. Bioanal. Chem. 401(1), 65–73 (2011).
   PubMed Web of Science ®Google Scholar
• Cornett DS , FrappierSL, CaprioliRM. MALDI-FTICR imaging MS of drugs and metabolites in tissue. Anal. Chem. 80(14), 5648–5653 (2008).
   PubMed Web of Science ®Google Scholar
• Walch A , RauserS, DeiningerSO, HoflerH. MALDI imaging MS for direct tissue analysis: a new frontier for molecular histology. Histochem. Cell Biol. 130(3), 421–434 (2008).
   PubMed Web of Science ®Google Scholar
• Bristow A . Accurate mass measurement for the determination of elemental formula – a tutorial. Mass Spectrom. Rev. 25(1), 99–111 (2006).
   PubMed Web of Science ®Google Scholar
• McLafferty F . Interpretation of Mass Spectra. University Science Books, Herndon, VA, USA (1980)
   Google Scholar
• Miura D , TsujiY, TakahashiK, WariishiH, SaitoK. A strategy for the determination of the elemental composition by fourier transform ion cyclotron resonance MS based on isotopic peak ratios. Anal. Chem. 82(13), 5887–5891 (2010).
   PubMed Web of Science ®Google Scholar
• Clauser KR , BakerP, BurlingameAL. Role of accurate mass measurement (+/-10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71(14), 2871–2882 (1999).
   PubMed Web of Science ®Google Scholar
• Fjeldsted J . The mass defect, isotope clusters and accurate mass for elemental determination. In: Liquid Chromatography Time-Of-Flight Mass Spectrometry. Wiley, 17–34 (2009)
   Google Scholar
• Cameron A , Wichers E. Report of the international commission on atomic weights. J. Am. Chem. Soc. 84(22), 4175–4197 (1962).
   Web of Science ®Google Scholar
• Volmer DA , LeslieA. Dealing with the masses: a tutorial on accurate masses, mass 32 uncertainties, and mass defects. Spectroscopy 1 June (2007)
   Web of Science ®Google Scholar
• Godwin H . Half-life of radiocarbon. Nature195, 984–984 (1962).
   Web of Science ®Google Scholar
• Zhang H , ZhangD, RayK. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J. Mass Spectrom. 38(10), 1110–1112 (2003).
   PubMed Web of Science ®Google Scholar
• Holcapek M , KolarovaL, NobilisM. High-performance liquid chromatography-tandem MS in the identification and determination of phase I and phase II drug metabolites. Anal. Bioanal. Chem. 391(1), 59–78 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang H , ZhangD, RayK, ZhuM. Mass defect filter technique and its applications to drug metabolite identification by high-resolution MS. J. Mass Spectrom. 44(7), 999–1016 (2009).
   PubMed Web of Science ®Google Scholar
• Sleno L . The use of mass defect in modern MS. J. Mass Spectrom. 47(2), 226–236 (2012).
   PubMed Web of Science ®Google Scholar
• Zhu M , MaL, ZhangDet al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution MS data. Drug Metab. Dispos. 34(10), 1722–1733 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang H , ZhuM, RayK, MaL, ZhangD. Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite identification. Rapid Commun. Mass Spectrom. 22(13), 2082–2088 (2008).
   PubMed Web of Science ®Google Scholar
• Watson J . Introduction to Mass Spectometry. Raven Press, NY, USA (1985).
   Google Scholar
• Ferrer I , ThurmanE. Liquid Chromatography Time-of-Flight MS: Principles, Tools and Applications for Accurate Mass Analysis. John Wiley & Sons, Hoboken, NJ, USA (2009).
   Google Scholar
• Marshall AG , Hendrickson CL. High-resolution mass spectrometers. Annu. Rev. Anal. Chem. (Palo. Alto. Calif.)1, 579–599 (2008).
   PubMed Web of Science ®Google Scholar
• Allwood JW , Goodacre R. An introduction to liquid chromatography–MS instrumentation applied in plant metabolomic analyses. Phytochem. Anal. 21(1), 33–47 (2010).
   PubMed Web of Science ®Google Scholar
• Perry RH , CooksRG, NollRJ. Orbitrap MS: instrumentation, ion motion and applications. Mass Spectrom. Rev. 27(6), 661–699 (2008).
   PubMed Web of Science ®Google Scholar
• Schaub TM , HendricksonCL, HorningS, QuinnJP, SenkoMW, MarshallAG. High-performance MS: Fourier transform ion cyclotron resonance at 14.5 Tesla. Anal. Chem. 80(11), 3985–3990 (2008).
   PubMed Web of Science ®Google Scholar
• Wright P . Metabolite identification by MS: 40 years of evolution. Xenobiotica41(8), 670–686 (2011).
   PubMed Web of Science ®Google Scholar
• Liang Y , WangG, XieL, ShengL. Recent developments in liquid chromatography/MS and emerging technologies for metabolite identification. Curr. Drug Metab. 12(4), 329–344 (2011).
   PubMed Web of Science ®Google Scholar
• Pelander A , DeckerP, BaessmannC, OjanperaI. Evaluation of a high resolving power time-of-flight mass spectrometer for drug analysis in terms of resolving power and acquisition rate. J. Am. Soc. Mass Spectrom. 22(2), 379–385 (2011).
   PubMed Web of Science ®Google Scholar
• Bateman K , Castro-PerezJ, WronaMet al. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun. Mass Spectrom. 21(9), 1485–1496 (2007).
   PubMed Web of Science ®Google Scholar
• Dear G , Munoz-MuriedasJ, BeaumontCet al. Sites of metabolic substitution: investigating metabolite structures utilising ion mobility and molecular modeling. Rapid Commun. Mass Spectrom. 24(21), 3157–3162 (2010).
   PubMed Web of Science ®Google Scholar
• Shimiziu A , OheT, ChibaM. A novel method for the determination of the site of glucuronidation by ion mobility spectrometry-MS. Drug Metabolism Disposition40(8), 1456–1459 (2012).
   PubMed Web of Science ®Google Scholar
• Kanu A , DwivediP, TamM, MatzL, Hill Jr H. Ion mobility-MS. J. Mass Spectrom. 43(1), 1–22 (2008).
   PubMed Web of Science ®Google Scholar
• Verbeck G , RuotoloB, SawyerH, GilligK, RussellD. A fundamental introduction to ion mobility MS applied to the analysis of biomolecules. J. Biomolecular Tech. 13(2), 56–61 (2002).
   PubMedGoogle Scholar
• Smith D , KnapmanT, CampuzanoIet al. Deciphering drift time measurements from travelling wave ion mobility spectrometry- MS studies. Eur. J. Mass Spectrom. 15, 113–130 (2009).
   PubMed Web of Science ®Google Scholar
• Marshall A , HendricksonC, JacksonG. Fourier transform ion cyclotron resonance MS: a primer. Mass Spec.Reviews17(1), 1–35 (1998).
   PubMed Web of Science ®Google Scholar
• Scigelova M , HornshawM, GiannakopulosA, MakarovA. Fourier transform MS. Mol.Cell Proteomics10(7), M111.009431 (2011).
   PubMed Web of Science ®Google Scholar
• Heeren R , KleinnijenhuisA, McDonnellL, MizeT. A mini-review of MS using high-performance FTICR-MS methods. Anal. Bioanal. Chem. 378(4), 1048–1058 (2004).
   PubMed Web of Science ®Google Scholar
• Makarov A . Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis. Anal. Chem. 72(6), 1156–1162 (2000).
   PubMed Web of Science ®Google Scholar
• Perry R , CooksG, NollR. Orbitrap MS: Instrumentation, ion motion and applications. Mass Spectrom. Rev. 27(6), 661–699 (2008).
   PubMed Web of Science ®Google Scholar
• Scigelova M , Makarov A. Advances in bioanalytical LC–MS using the OrbitrapTM mass analyzer. Bioanalysis1(4), 741–754 (2009).
   PubMed Web of Science ®Google Scholar
• Michalski A , DamocE, LangeOet al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap® Elite) facilitates top down LC–MS/MS and versatile peptide fragmentation modes. Mol. Cell Proteomics11(3), O111.013698 (2012).
   PubMed Web of Science ®Google Scholar
• Yuan M , BreitkopfSB, YangX, AsaraJM. A positive/negative ion-switching, targeted MS-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7(5), 872–881 (2012).
   PubMed Web of Science ®Google Scholar
• Liu DQ , ArisonBH, StearnsRA, KimD, VincentSH. Characterization of two cyclic metabolites of sitagliptin. Drug Metab. Dispos. 35(4), 521–524 (2007).
   PubMed Web of Science ®Google Scholar
• Dealler SF , HawkeyPM, MillarMR. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J. Clin. Microbiol. 26(10), 2152–2156 (1988).
   PubMed Web of Science ®Google Scholar
• Picard N , DridiD, SauvageFL, BoughattasNA, MarquetP. General unknown screening procedure for the characterization of human drug metabolites: application to loratadine phase I metabolism. J. Sep. Sci. 32(13), 2209–2217 (2009).
   PubMed Web of Science ®Google Scholar
• Li AC , GohdesMA, ShouWZ: ‘N-in-one’ strategy for metabolite identification using a liquid chromatography/hybrid triple quadrupole linear ion trap instrument using multiple dependent product ion scans triggered with full mass scan. Rapid Commun. Mass Spectrom. 21(8), 1421–1430 (2007).
   PubMed Web of Science ®Google Scholar
• Lim H , ChenJ, CookyK, SensenhauserC, SilvaJ, EvansD. A generic method to detect electrophilic intermediatesusing isotopic pattern triggered data-dependent high-resolution accurate MS. Rapid Commun. Mass Spectrom. 22(8), 1295–1311 (2008).
   PubMed Web of Science ®Google Scholar
• Yu LJ , ChenY, DeninnoMP, O’ConnellTN, HopCE. Identification of a novel glutathione adduct of diclofenac, 4´-hydroxy-2´-glutathion-deschloro-diclofenac, upon incubation with human liver microsomes. Drug Metab. Dispos. 33(4), 484–488 (2005).
   PubMed Web of Science ®Google Scholar
• Castro-Perez J , PlumbR, LiangL, YangE. A high-throughput liquid chromatography/tandem MS method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun. Mass Spectrom. 19(6), 798–804 (2005).
   PubMed Web of Science ®Google Scholar
• Barbara J , Castro-Perez J. High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening. Rapid Commun. Mass Spectrom. 25(20), 3029–3040 (2011).
   PubMed Web of Science ®Google Scholar
• Erve J , BeyerC, ManzinoL, TalaatR. Metabolite identification in rat brain microdialysates by direct infusion nanoelectrospray ionization after desalting on a ZipTip and LTQ/Orbitrap MS. Rapid Commun. Mass Spectrom. 23(24), 4003–4012 (2009).
   PubMed Web of Science ®Google Scholar
• Ruan Q , Zhu M. Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap MS and an improved mass defect filtering technique. Chem. Res. Toxicol. 23(5), 909–917 (2010).
   PubMed Web of Science ®Google Scholar
• Tiller P , YuS, BatemanKet al. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies. Rapid Commun. Mass Spectrom. 22(22), 3510–3516 (2008).
   PubMed Web of Science ®Google Scholar
• Zhu M , MaL, ZhangH, GriffithW. Detection and structural characterization of glutathione-trapped reactive metabolites using liquid-chromatography–high-resolution MS and mass defect filtering. Anal. Chem. 79(21), 8333–8341 (2007).
   PubMed Web of Science ®Google Scholar
• Zhu M , ZhangH, Griffith Humphreys W. Drug metabolite profiling and identification by high-resolution MS. J. Biol. Chem. 286(29), 25419–25425 (2011).
   PubMed Web of Science ®Google Scholar
• Yu C , ChenC, GoryckiF, NeissT. A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/MS and radiometric detection. Rapid Commun. Mass Spectrom. 21(4), 497–502 (2007).
   PubMed Web of Science ®Google Scholar
• Vishwanathan K , BabalolaK, WangJet al. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR. Addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards. Chem. Res. Toxicol. 22(2), 311–322 (2009).
   PubMed Web of Science ®Google Scholar
• Walker GS , RyderTF, SharmaR, SmithEB, FreundA. Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR. Drug Metab. Disp. 39(3), 433–440 (2011).
   PubMed Web of Science ®Google Scholar
• Ma S , LiZ, LeeK, ChowdhuryS. Determination of exposure multiples of human metabolites for MIST assessment in preclinical safety species without using reference standards or radiolabeled compounds. Chem. Res. Toxicol. 23(12), 1871–1873 (2010).
   PubMed Web of Science ®Google Scholar
• Yang Y , GrubbM, LukC, Griffith-HumphreysW, JosephsJ. Quantitative estimation of circulating metabolites without synthetic standards by using ultra-high-performance liquid chromatography/high resolution accurate MS in combination with UV correction. Rapid. Commun. Mass Spectrom. 25(21), 3245–3251 (2011).
   PubMed Web of Science ®Google Scholar
• Ramanathan R , RaghavanN, ComezogluS, Griffith Humphreys W. A low flow ionization technique to integrate quantitative and qualitative small molecule bioanalysis. Int. J. Mass Spectrom. 301(1–3), 127–135 (2011).
   Web of Science ®Google Scholar
• Schadt S , ChenL, BischoffD. Evaluation of relative LC–MS response of metabolites to parent drug in LC/nanospray ionization MS: potential implications in MIST assessment. J. Mass Spectrom. 46(12), 1281–1286 (2011).
   PubMed Web of Science ®Google Scholar
• Hamilton RA , GarnettWR, KlineBJ. Determination of mean valproic acid serum level by assay of a single pooled sample. Clin. Pharmacol. Ther. 29(3), 408–413 (1981).
   PubMed Web of Science ®Google Scholar
• Hopfgartner G , BourgogneE. Quantitative high-throughput analysis of drugs in biological matrices by MS. Mass Spectrom. Rev. 22(3), 195–214 (2003).
   PubMed Web of Science ®Google Scholar
• van Dongen WD , NiessenWM. LC–MS systems for quantitative bioanalysis. Bioanalysis4(19), 2391–2399 (2012).
   PubMed Web of Science ®Google Scholar
• Rousu T , TolonenA. Comparison of unit resolution SRM and TOF-MS at 12,000 mass resolution for quantitative bioanalysis of 11 steroids from human plasma. Bioanalysis4(5), 555–563 (2012).
   PubMed Web of Science ®Google Scholar
• Dillen L , CoolsW, VereykenLet al. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis4(5), 565–579 (2012).
   PubMed Web of Science ®Google Scholar
• Acquadro E , CabellaC, GhianiS, MiragoliL, BucciEM, CorpilloD. Matrix-assisted laser desorption ionization imaging MS detection of a magnetic resonance imaging contrast agent in mouse liver. Anal. Chem. 81(7), 2779–2784 (2009).
   PubMed Web of Science ®Google Scholar

Websites

• FDA Guidance for Industry. Safety Testing of Drug Metabolites (2008). www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079266.pdf
   Google Scholar
• ICH Topic M 3 (R2): non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals (2009). www.ema.europa.eu/pdfs/human/ich/028695en.pdf
   Google Scholar